A-share Subscription | Anda Co., Ltd. (920202.BJ) opens for subscription, with clients including Volkswagen Group, SAIC Motor Corporation, etc.
On September 16, Anda Co., Ltd. (920202.BJ) opened for subscription, with an issue price of 7.55 yuan per share, a subscription cap of 1.19 million shares, and a price-to-earnings ratio of 13.50 times. It is listed on the Beijing Stock Exchange, with Caitong Securities as its sponsor.
On September 16, Anda Co., Ltd. (920202.BJ) opened for subscription, with an issue price of 7.55 yuan per share, a subscription of 1.19 million shares, and a price-to-earnings ratio of 13.50 times. It is listed on the Beijing Stock Exchange, with Caitong as its sponsor.
According to the prospectus, the company is mainly engaged in the research and development, production, and sales of precision aluminum alloy die-castings for automobiles. Its main products include: powertrain system components such as oil pans and covers; new energy three-electric system components such as inverter housings and motor housings; and suspension system components such as mounting brackets.
Through years of market development and customer accumulation, the company has established long-term stable cooperative relationships with its main customers. During the reporting period, the company's main customers were well-known domestic and international automobile OEMs and Tier 1 auto parts suppliers, including Volkswagen Group, SAIC Motor Corporation, SAIC General Motors, SAIC Volkswagen, Hyundai Transys, Zhejiang EV-Tech, and China FAW, among others.
The company mainly generates profits through the research and development, production, and sales of precision aluminum alloy die-casting products for automobiles. The company's products are customized products, developed, designed, and mass-produced according to customers' specific needs. It mainly adopts a "production based on sales, procurement based on production" model for procurement and production, and mainly sells to automobile OEMs and Tier 1 auto parts suppliers.
Die casting refers to a metal casting process in which molten metal is injected under high pressure into a die-casting mold and cooled and formed under pressure. Compared with other casting technologies, die casting technology is the most advanced and efficient, and is a near-net-shape metal hot working forming technology with little or no cutting. Precision die-casting products are favored by many manufacturing enterprises for their thin walls, complex shapes, fine dimensions, and smooth surfaces, and are thus widely used in many industries such as automobiles, communications infrastructure equipment, electromechanical, home appliances, and medical equipment.
During the reporting period, the company's main business revenue classified by product category is as follows:
According to the "Guidelines for Industry Statistical Classification of Listed Companies of the China Association of Listed Companies" issued by the China Association of Listed Companies, the company's industry belongs to "Automobile Manufacturing (C36)" - "Automobile Parts and Accessories Manufacturing (C367)"; according to the National Bureau of Statistics' "Industrial Classification of the National Economy (GB/T4754-2017)", the company's industry belongs to "Automobile Manufacturing (C36)" - "Automobile Parts and Accessories Manufacturing (C3670)".
In terms of financials, for the 2023, 2024, and 2025 fiscal years, the company achieved operating revenue of approximately 924 million yuan, 911 million yuan, and 1.015 billion yuan, respectively; during the same periods, net profit was approximately 58 million yuan, 58 million yuan, and 70 million yuan, respectively.
Related Articles

New Stock News | Zhejiang Jingxin Pharmaceutical (002020.SZ) Files Again with HKEX, Has Successfully Launched Class 1 Innovative Drug Didaxini
.png)
New Stock News | Zhejiang Jingxin Pharmaceutical (002020.SZ) Files Again with the Hong Kong Stock Exchange

CITIC SEC: Ultimate Heat Dissipation Arrives, Diamond Ushers in Its First Year of Industrialization
New Stock News | Zhejiang Jingxin Pharmaceutical (002020.SZ) Files Again with HKEX, Has Successfully Launched Class 1 Innovative Drug Didaxini

New Stock News | Zhejiang Jingxin Pharmaceutical (002020.SZ) Files Again with the Hong Kong Stock Exchange
.png)
CITIC SEC: Ultimate Heat Dissipation Arrives, Diamond Ushers in Its First Year of Industrialization

RECOMMEND





